Evaluating antibiotic therapy for ventilator-associated pneumonia caused by gram-negative bacilli

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pulmonology

Background:

• Ventilator-associated pneumonias (VAPs) are a significant complication in intensive care units (ICUs), increasing patient morbidity and mortality.
• Gram-negative bacilli (GNR) are common pathogens causing VAPs, with prolonged antibiotic courses (10-14 days) traditionally being the standard of care.

Purpose of the Study:

• To assess risk factors for recurrent GNR VAPs in trauma patients.
• To evaluate the effectiveness of current antibiotic treatment durations for GNR VAPs.

Main Methods:

• A retrospective review of trauma patients who developed VAP between February 2019 and May 2022.
• Analysis of patient demographics, injury characteristics, VAP details (pathogen, antibiotics, duration), and recurrence rates.
• Comparison of single versus multiple GNR VAP episodes.

Main Results:

• Eleven out of fifty trauma patients developed GNR VAP.
• Six patients experienced recurrent GNR infections, including *Pseudomonas aeruginosa* and *Enterobacter aerogenes*.
• Half of the patients receiving 10-day antibiotic treatment suffered a recurrence, with no significant difference in microbiology or duration between single and recurrent episodes.

Conclusions:

• Recurrent GNR VAPs remain a concern despite prolonged antibiotic therapy.
• Further investigation is required to establish optimal treatment strategies to minimize VAP recurrence in ICU patients.